What is Intercede Health?
Founded in 1995, Intercede Health operates as a critical intermediary in the healthcare ecosystem, focusing on the management of complex health conditions. The company provides a comprehensive suite of services, including hospitalist network management and post-discharge transitional care. By collaborating closely with health plans and physician partners, Intercede Health ensures continuity of care, which is essential for improving patient outcomes. Their service model has evolved to incorporate in-home care and telemedicine, effectively addressing the needs of patients with chronic conditions. This multi-faceted approach allows the company to bridge the gap between acute hospital admissions and long-term recovery, thereby reducing readmission rates and optimizing the overall clinical pathway for high-acuity populations.
How much funding has Intercede Health raised?
Intercede Health has raised a total of $326K across 2 funding rounds:
Debt
$150K
Debt
$176K
Debt (2020): $150K with participation from PPP
Debt (2021): $176K led by PPP
Key Investors in Intercede Health
PPP
Public-Private Partnership
What's next for Intercede Health?
With this late-stage capital injection, Intercede Health is well-positioned to accelerate its strategic growth initiatives. The company is expected to further integrate its telemedicine capabilities and expand its in-home care services to meet the rising demand for decentralized healthcare delivery. As the industry shifts toward value-based care models, Intercede Health's ability to manage complex patient transitions will likely serve as a primary driver for future market expansion. The firm will likely focus on deepening its partnerships with health plans to scale its hospitalist network, ensuring that its clinical interventions remain both scalable and effective in a post-pandemic environment. This strategic deployment of resources will be pivotal in maintaining their competitive advantage in the transitional care market.
See full Intercede Health company page
